What Real Science in Women’s Health Looks Like

What Real Science in Women’s Health Looks Like

Author: by FemmeHealth Alliance August 21, 2025 Duration: 25:15

Half the population experiences these conditions. Many are universal, recurring, and clinically significant. Yet in the eyes of too many investors, women’s health therapeutics remain “optional.”

In this episode of Blindspot Capital, I sit down with Sabrina Johnson, President & CEO of Daré Bioscience, to unpack the misconceptions holding back investment in women’s health from contraception to menopause to vaginal health and explore how disciplined science can change the game.

In This Episode We Cover:

🟣 Why women’s health markets are larger and more recurrent than most investors realize

🟣 The false perception that women’s health conditions are “lifestyle” or “optional”

🟣 The reality of recruiting participants for women’s health trials (and why stigma isn’t a barrier)

🟣 What scientific credibility really looks like in biotech and how to protect it

🟣 The difference between medicine and marketing and why the distinction matters for investors

🟣 Why angel investors have a leadership opportunity in women’s health

Join 10,000+ readers of the FemmeHealth newsletter on Substack.

------------------------------

Why You Should Listen If you care about women’s health, biotech, or the intersection of science and capital, this is a clear-eyed look at the market opportunities hiding in plain sight and the leadership it will take to unlock them.

About Sabrina Johnson Sabrina Johnson is the President & CEO of Daré Bioscience, a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority. Daré believes that innovation does not have to start from scratch.

The company’s goal is to bring to market as soon as practicable innovative evidence-based solutions that address decades of unmet needs in women’s health and enhance outcomes and convenience, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Learn more Here

🎧 Listen now and share with someone who still thinks women’s health is “niche.”

📌 Watch on YouTube



Get full access to The Billion Dollar Blindspot at blog.billiondollarblindspot.com/subscribe

There's a vast, often overlooked frontier in business and innovation, and Blindspot Capital is mapping its terrain. This podcast digs into the ideas, trends, and tangible investment potential shaping the future of women's health, a sector that has historically been underfunded and underserved. Each episode moves beyond surface-level discussions to examine the systemic gaps and the consequential opportunities they create. You'll hear from founders, investors, researchers, and thinkers who are actively building and funding solutions in this space, sharing their on-the-ground experiences and hard-won insights. The conversations are grounded in the reality of entrepreneurship and market dynamics, exploring not just the "why" but the "how"-how new technologies are being applied, how businesses are scaling, and how capital can be deployed to generate both impact and returns. Tune in for a clear-eyed look at an area ripe for transformation, where understanding the blind spot isn't just about awareness, but about seeing a path forward for savvy builders and backers alike. This isn't a niche side conversation; it's a central dialogue about the next wave of growth in healthcare and technology, delivered through a podcast dedicated to substantive, forward-thinking analysis.
Author: Language: English Episodes: 18

Blindspot Capital
Podcast Episodes
The Menopause Information Crisis [not-audio_url] [/not-audio_url]

Duration: 31:16
Some markets follow a familiar script: a need emerges, founders respond, capital flows, and eventually, the sector matures. But women’s health doesn’t work like that.In a recent episode of Blindspot Capital, I sat down w…
Building FemTech Infrastructure in Asia [not-audio_url] [/not-audio_url]

Duration: 39:33
Some markets follow this script: A need appears. Entrepreneurs respond. Capital flows in. Eventually, the sector matures and innovation accelerates. But some markets don’t follow that script.In a recent episode of Blinds…
Why It Takes Years to Build in Women’s Health [not-audio_url] [/not-audio_url]

Duration: 34:44
Most innovation stories are told as clean upward lines. A founder has an idea. Investors come in. The product launches. Growth follows. Eventually there is an acquisition or an IPO, and the story looks inevitable in hind…
Why Women’s Heart Disease Is Still Misdiagnosed [not-audio_url] [/not-audio_url]

Duration: 34:58
In this episode of Blindspot Capital, Maryann sits down with Professor Angela Maas (cardiologist and pioneer of sex- and gender-specific cardiology) to unpack why women’s heart disease is still misunderstood and what med…
Tough Love for Women’s Health Founders [not-audio_url] [/not-audio_url]

Duration: 26:51
In this episode of Blindspot Capital, Maryann sits down with Lisa Suennen - longtime healthcare investor, founder of the Venture Valkyrie blog, and Managing Partner of the Go Red for Women Venture Fund to unpack one of t…
The Silent Ban: How Social Media Is Censoring Women’s Health [not-audio_url] [/not-audio_url]

Duration: 25:58
In this episode of Blindspot Capital, Maryann sits down with Anna O’Sullivan, co-founder of censhership.co.uk and FutureFemHealth, to unpack a deeply underrecognized systemic bias: the routine censorship of women’s healt…
Why Most Digital Health Startups Will Fail [not-audio_url] [/not-audio_url]

Duration: 30:18
Half the headlines in healthcare are hype. But what if we stopped chasing the next shiny thing and started fixing the fundamentals?In this episode of Blindspot Capital, I sit down with Sergei Polevikov, mathematician, in…